1.Laboratory markers for chronic exercise alcohol consumers.
Journal of Korean Neuropsychiatric Association 1992;31(5):909-915
No abstract available.
Biomarkers*
2.Biologic Markers Based on the Pathophysiology of PIH.
Korean Journal of Perinatology 1999;10(3):298-305
No abstract available.
Biomarkers*
3.Applications of Basic Experimental and Clinical Research Using Biomarkers.
International Neurourology Journal 2018;22(4):226-227
No abstract available.
Biomarkers*
4.Application of New Biochemical Markers in the Method of Diuretic Therapy for Ascites.
The Korean Journal of Hepatology 2000;6(1):1-2
No abstract available.
Ascites*
;
Biomarkers*
5.Clinical Implication of Tumor Markers.
Korean Journal of Medicine 2012;83(2):197-199
No abstract available.
Biomarkers, Tumor
6.Is Dynamic Left Ventricular Dyssynchrony a Novel Surrogate Marker in the Patient with Hypertension?.
Journal of Cardiovascular Ultrasound 2012;20(4):172-173
No abstract available.
Biomarkers
;
Humans
7.Biochemical Marker of Bone Metabolism.
Journal of Korean Society of Pediatric Endocrinology 2006;11(2):131-137
No abstract available.
Biomarkers*
;
Metabolism*
8.Tumor Markers in Gastric Cancer.
Journal of the Korean Gastric Cancer Association 2002;2(4):191-194
No abstract available.
Stomach Neoplasms*
;
Biomarkers, Tumor*
9.New biomarkers in atopic dermatitis.
Allergy, Asthma & Respiratory Disease 2017;5(2):61-62
No abstract available.
Biomarkers*
;
Dermatitis, Atopic*
10.Clinical Significance of Serum CEA, CA19-9, and CA125 Level Changes in Periampullary Cancer.
Mu Yeol PARK ; Sehwan HAN ; Seok Yong RYU ; Myung Soo LEE ; Hong Joo KIM ; Young Duck KIM ; Hong Yong KIM
Journal of the Korean Surgical Society 1998;54(1):62-67
Numerous tumor markers have been investigated and have been in clinical use for the management of cancer patients. Among them, carcimoembryonic antigen(CEA), CA19-9, and CA125 are the most commonly used tumor markers in periampullary cancer. We carried out this study to estimate the usefulness of these three tumor markers in the management of periampullary cancer. The serum levels of CEA, CA19-9, and CA125 were measured in 55 patients between Jan. 1990 and Feb. 1997. We also valuated the changes in the levels of these three tumor markers after surgery. The serum level of CEA was elevated in 30 patients(60%) preoperatively. The serum level of CA19-9 was elevated in 38 patients(83%), and the serum CA125 level was elevated in 13 patients(59%) preoperatively. The CA19-9 levels decreased in 20(95%) of 21 patients who had received a tumor resection, while only one of those patients had an elevated level of serum CA19-9 postoperatively. Similarly, the CEA levels decreased in 23(88%) of 26 patients who had received a tumor resection. The mean level of CA19-9 has higher in advanced stages than in early stages, but this difference was not statistically significant. In conclusion, there was no single reliable tumor marker in periampullary cancer. However, CA19-9 was the most sensitive tumor marker among the three.
Biomarkers, Tumor
;
Humans
Result Analysis
Print
Save
E-mail